Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension

Published:2016-12 Issue:6 Volume:68 Page:542-547
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Tokunaga Naoto,Ogawa Aiko,Ito Hiroshi,Matsubara Hiromi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era;Humbert;Circulation,2010

2. Predicting survival in pulmonary arterial hypertension in the UK;Lee;Eur Respir J,2012

3. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry;Benza;Chest,2012

4. Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan;Ogawa;Life Sci,2014

5. Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits;Armstrong;Br J Pharmacol,1978

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Initial Triple Combination Therapy Including Intravenous Prostaglandin I<sub>2</sub> for the Treatment of Patients with Severe Pulmonary Arterial Hypertension;International Heart Journal;2023-07-29

3. A Review of Modern and Traditional Approaches for the Management of Pulmonary Hypertension;Current Traditional Medicine;2023-07-12

4. Impact of malnutrition on prognosis in patients with pulmonary arterial hypertension;Pulmonary Circulation;2023-07

5. Should We Change the Target of Therapy in Pulmonary Hypertension?;Life;2023-05-17